Navigation Links
Bupa International Growth in China Leads to Drop in Premiums for Pacific Prime SME Clients
Date:5/30/2013

Hong Kong (PRWEB) May 31, 2013

Pacific Prime’s SME clients can look forward to lower premium rates as Bupa International have announced further discounts on standard premiums for their Company plans in China.

Bupa Intl are focussing on increasing their already growing market share in Asia and believe that reducing the premiums of their SME plans in China by 30% across the board will help to show their commitment to the region.

Both Pacific Prime and Bupa International anticipate a very positive response from this new offer as clients will now be able to receive some of the highest level of coverage available, with a market competitive premium.

Bupa’s individual plans have already performed well in Asia but this move to reduce SME premiums is an attempt to gather more Chinese companies as clients. The insurer is highly confident that this premium reduction will help continue to build their SME portfolio that has been so successful for them in other parts of the world.

Currently, Bupa offers three basic plan options on their company insurance plans; Essential, Classic and Gold plans. Whilst these plans are exceptionally comprehensive in their coverage, Pacific Prime believes that they could be even more successful if they had the ability to tailor benefits.

Chinese businesses looking for insurance plans for SME groups tend to favour customisable plans which have the ability to e.g. limit a plan to a specific region of China or to a group of hospitals. Pacific Prime analysts are of the opinion that plans which are more catered specifically to China and Chinese clients have been more successful in the region.

A number of Chinese companies are requesting that the geographical coverage of Bupa’s policies be reduced to just China (as opposed to international coverage).This will reduce the cost of premiums for SME companies, however Pacific Prime do not believe this strategy to be beneficial overall.

Firstly, as China has some of the most expensive healthcare and hospitals in the world, the premiums for coverage in China alone are already high, and so the total cost is not that significantly reduced. Secondly, the large percentage of expats in the workforce in China often want to receive healthcare in their home countries due to the comfort of familiar language and culture, which would not be possible under these China only SME policies.

As an alternative, Bupa could tailor plans to restrict or prohibit cover at facilities that have higher than average costs of treatment (High Cost Providers - HCP). If policyholders want to receive treatment at these HCPs then they can do so under a co-payment policy whereby they pay 20% of the treatment costs.

For Bupa to maximise their growth in China, they must remain competitive with other insurers in the SME market. To do this, Bupa have already taken a significant step in reducing premium costs, and must also offer more flexible options for their clients’ plans in China for future success.

Read the full story at http://www.prweb.com/releases/bupa-international-reduce/plan-premiums-in-china/prweb10753897.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. International breast health global summit will focus on supportive care and quality of life
2. International conference to explore health of descendants of transatlantic slave trade
3. Kessler Foundation researchers present at first International Congress on Cognition in MS
4. Internationally known expert in ovarian cancer to be honored at the ASCO Annual Meeting
5. Nobel laureate to keynote international pharmaceutical conference at URI
6. International Nanomedicine Conference bound for Sydney: July 2-4, 2012
7. June 2012 marks a milestone for International Urogynecology Associates as Dr. Robert D. Moore and Dr. John R. Miklos perform their 24th Neovagina Surgery in 24 months
8. Heavy Duty Alternators and Starters Expert Elreg Distributors Ltd. Meets Needs of International Market with Launch of Spanish Website
9. The US Drug Watchdog Now Urges Plaintiffs Law Firms Worldwide To Contact Them About A Possible International Effort To Help Victims Of Defective Drugs Or Medical Devices
10. RMAX International to donate Recuper8 - a free, health - restoring program to Everyone in Uniform
11. International symposium on veterinary rehabilitation and physical therapy to be held in Vienna
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... ... in order to improve teacher quality, the field must first improve teacher preparation ... popular reform to the next” and that decades of input- and outcome-based research ...
(Date:3/28/2017)... ... March 28, 2017 , ... Greenfield ... Williamson brings his extensive knowledge of appraisals, property values, ad valorem taxation, and ... estate valuation industry for more than 40 years. , “Ruel is a great ...
(Date:3/28/2017)... ... , ... Dr. Isabella Wentz, PharmD, FASCP, one of the leading thyroid experts ... Secret. Dr. Wentz talked about journey and research recently on a blog and discussed ... the only solution to deal with thyroid disease. , Dr. Wentz completed her ...
(Date:3/28/2017)... ... 2017 , ... Via Oncology, the leading provider of oncology ... public-facing tool for analyzing the costs of various drug regimens in cancer care. ... patients, providers, insurers and pharmaceutical companies about the estimated costs of treatment options. ...
(Date:3/28/2017)... ... March 28, 2017 , ... Usually, the impending arrival of warmer weather ... those self-conscious about a double chin, this means more anxiety than elation. The cosmetic ... “For most people, a double chin is undesirable,” Dr. Goldman said, “but it seems ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017 The ... (dupilumab) injection to treat adults with moderate-to-severe eczema ... eczema is not controlled adequately by topical therapies, ... advisable. Dupixent can be used with or without ... demonstrates our commitment to approving new and innovative ...
(Date:3/28/2017)...  "US Cancer Generics Market Outlook 2022" report ... trend analysis related to the emergence and integration ... in US. The report analyzes various clinical and ... generics drugs in recent years. The introduction of ... dollars for various stake holders involved US cancer ...
(Date:3/28/2017)... , Va. and PHOENIX , March 28, ... Avella Specialty Pharmacy released a new white ... allergies and the use of latex in healthcare. Specifically, there ... in healthcare. In fact, the FDA has urged manufacturers to ... latex" claim from labels, because of the challenge to ensure ...
Breaking Medicine Technology: